Aroa Biosurgery (ASX:ARX) ROCE % : -7.59% (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Aroa Biosurgery ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Aroa Biosurgery's annualized ROCE % for the quarter that ended in Sep. 2023 was -7.59%.

Aroa Biosurgery ROCE % Historical Data

The historical data trend for Aroa Biosurgery's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aroa Biosurgery ROCE % Chart

Aroa Biosurgery Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

ROCE %

-23.85

-8.86

-0.35

Aroa Biosurgery Semi-Annual Data
	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
ROCE %	Get a 7-Day Free Trial			-9.80	-5.97	5.69	-6.32	-7.59

Aroa Biosurgery ROCE % Calculation

Aroa Biosurgery's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	-0.354	/	( ( (104.706 - 6.238)	+	(109.071 - 7.405) )	/ 2 )
	=	-0.354	/	( (98.468	+	101.666)	/ 2 )
	=	-0.354	/	100.067
	=	-0.35 %

Aroa Biosurgery's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Mar. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Mar. 2023 )		(Q: Sep. 2023 )
	=	-7.496	/	( ( (109.071 - 7.405)	+	(104.592 - 8.683) )	/ 2 )
	=	-7.496	/	( ( 101.666	+	95.909 )	/ 2 )
	=	-7.496	/	98.7875
	=	-7.59 %

(1) Note: The EBIT data used here is two times the semi-annual (Sep. 2023) EBIT data.

Aroa Biosurgery (ASX:ARX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Aroa Biosurgery ROCE % Related Terms

Thank you for viewing the detailed overview of Aroa Biosurgery's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Aroa Biosurgery (ASX:ARX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022

Website

https://www.aroabio.com

Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Aroa Biosurgery (ASX:ARX) Headlines

No Headlines